Disodium alendronate formulations

Details Disodium alendronate formulations Disodium alendronate formulations

C - Chemistry, Metallurgy

07

F

C07F 9/38 (2006.01) A61K 31/66 (2006.01)

Patent

CA 2221844

Disclosed is a method for treating and for preventing bone loss in patients by administering a formulation of 4-amino-1-hydroxy-butylidene-1,1-bisphophonic acid, disodium salt, or its hydrates. Also described is a pharmaceutical composition containing said disodium salt in a pharmaceutically acceptable excipient.

Procédé de traitement et de prévention de la déperdition osseuse, par l'administration d'une préparation de sel disodique d'acide 4-amino-1-hydroxy-butylidène-1,1-bisphosphonique, ou de ses hydrates. Est également décrite une composition pharmaceutique contenant ce sel disodique dans un excipient pharmaceutiquement acceptable.

Affiliated with

Also associated with

Rating

Disodium alendronate formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Disodium alendronate formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Disodium alendronate formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1409157